Publication Beamlines Strategic Pillar
Reid, Joel W.; Kaduk, James A. (2021). Crystal structure of donepezil hydrochloride form III, C24H29NO3⋅HCl. Powder Diffraction 36(4) , 233-240. 10.1017/s0885715621000415. Health
Dong, Zichao; Zhou, Jianwei; Huang, Tianxin; Yan, Zhijie; Liu, Xin et al. (2022). Effects of oxygen on the adsorption/oxidation of aqueous Sb(III) by Fe-loaded biochar: An X-ray absorption spectroscopy study. Science of the Total Environment 846, 157414. 10.1016/j.scitotenv.2022.157414. Materials
Garcia-Martin, Susana; King, Graham; Urones-Garrote, Esteban; Woodward, Patrick M. (2021). Coupled Compositional and Displacive Modulations in KLaMnWO6 Revealed by Atomic Resolution Imaging. Journal of the American Chemical Society 143(45) . 10.1021/jacs.1c07426. Materials
Rakhmatullin, Aydar; Molokeev, Maxim S.; King, Graham; Polovov, Ilya B.; Maksimtsev, Konstantin V. et al. (2021). Polymorphs of Rb3ScF6: X-ray and Neutron Diffraction, Solid-State NMR, and Density Functional Theory Calculations Study. Inorganic Chemistry 60(8) , 6016-6026. 10.1021/acs.inorgchem.1c00485. Materials
(2021). Methods for improving response to anti-lif antibody treatment in individuals with cancer. Patent Number: IL279484A.
(2021). Combination of lif inhibitors and platinum-based antineoplastic agents for use in treating cancer. Patent Number: IL279444A.
(2021). ANTIBODY. Patent Number: PT3311170T.
(2022). Surgical method for treatment of auditory disease or condition. Patent Number: GB202213060D0.
(2022). Nanoparticle platform for antibody and vaccine delivery. Patent Number: PT3661968T.
(2021). MODELING TEST. Patent Number: PT3311169T.
(2021). Stable heterodimeric antibody design with mutations in the fc domain. Patent Number: PT2773671T.
(2022). ANTIBODY EPITOPE. Patent Number: PT3311171T.
호안 세오안 수아레즈; 후디트 아니도 폴구에이라; 요한 프란손; 로빈 매튜 할렛; 모니카 파스쿠알 가르시아 et al. (2021). Combination of LIF inhibitor and PD-1 axis inhibitor for use in treating cancer. Patent Number: KR20210021287A.
호안 세오안 수아레즈; 후디트 아니도 폴구에이라; 로빈 매튜 홀레트; 파트리샤 앤 깁린; 잔느 마그람 et al. (2021). Combination of LIF inhibitors and platinum-based anti-neoplastic agents for use in treating cancer. Patent Number: KR20210022065A.
호안 세오안 수아레즈; 후디트 아니도 폴구에이라; 로빈 매튜 홀레트; 피터 에드워드 베일리스; 아지타 제가나탄 et al. (2021). Methods for improving response to anti-LIF antibody treatment in a subject with cancer. Patent Number: KR20210024007A.